Zobrazeno 1 - 10
of 11
pro vyhledávání: '"S. M. Proudman"'
Autor:
A. Quinlivan, D. Neuen, D. Hansen, W. Stevens, L. Ross, N. Ferdowsi, S. M. Proudman, J. G. Walker, J. Sahhar, G-S. Ngian, D. Apostolopoulos, L. V. Host, G. Major, C. Basnayake, K. Morrisroe, M. Nikpour
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-8 (2024)
Abstract Background To determine the relationship between gastroesophageal reflux disease (GORD) and its treatment and interstitial lung disease in patients with systemic sclerosis (SSc). Methods SSc patients from the Australian Scleroderma Cohort St
Externí odkaz:
https://doaj.org/article/9b3157335fc64c0da7e5cc0c2bfdda25
Autor:
A, Quinlivan, V, Thakkar, W, Stevens, K, Morrisroe, D, Prior, C, Rabusa, P, Youssef, E, Gabbay, J, Roddy, J G, Walker, J, Zochling, J, Sahhar, P, Nash, S, Lester, M, Rischmueller, S M, Proudman, M, Nikpour
Publikováno v:
Internal medicine journal. 45(11)
Screening for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) is now standard care in this disease. The existing Australian Scleroderma Interest Group algorithm (ASIGSTANDARD ) is based on transthoracic echocardiography (TTE) and pu
Autor:
K A, Patterson, P J, Roberts-Thomson, S, Lester, J A, Tan, P, Hakendorf, M, Rischmueller, J, Zochling, J, Sahhar, P, Nash, J, Roddy, C, Hill, M, Nikpour, W, Stevens, S M, Proudman, J G, Walker
Publikováno v:
Arthritisrheumatology (Hoboken, N.J.). 67(12)
To determine the relationships between systemic sclerosis (SSc)-related autoantibodies, as well as their clinical associations, in a well-characterized Australian patient cohort.Serum from 505 Australian SSc patients were analyzed with a commercial l
Publikováno v:
Internal medicine journal. 45(3)
Pulmonary arterial hypertension (PAH) is a leading cause of morbidity and mortality in patients with systemic sclerosis (SSc). Approximately one in 10 will develop PAH during their lifetime. These patients have a worse prognosis than those with PAH d
Autor:
K B, Morrisroe, W, Stevens, H, Nandurkar, D, Prior, V, Thakkar, J, Roddy, J, Zochling, J, Sahhar, K, Tymms, A, Sturgess, G, Major, F, Kermeen, C, Hill, J, Walker, P, Nash, E, Gabbay, P, Youssef, S M, Proudman, M, Nikpour
Publikováno v:
Clinical and experimental rheumatology. 32(6 Suppl 86)
To determine the prevalence and correlates of antiphospholipid antibodies (APLA) in systemic sclerosis (SSc).Nine hundred and forty SSc patients were tested for APLA using an ELISA assay at recruitment. Clinical manifestations were defined as present
Autor:
R J, Black, L, Spargo, C, Schultz, B, Chatterton, L, Cleland, S, Lester, C L, Hill, S M, Proudman
Publikováno v:
Arthritis careresearch. 66(4)
Despite better disease suppression with combination disease-modifying antirheumatic drugs (DMARDs), some patients with rheumatoid arthritis (RA) have progressive erosive disease. The objective of this study was to determine whether hand bone mineral
Publikováno v:
Internal medicine journal. 40(7)
Interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH) represent the leading causes of death in systemic sclerosis (SSc). Screening for these complications has assumed greater importance, but is not universal. The aim of this study
Publikováno v:
Annals of the rheumatic diseases. 68(5)
Publikováno v:
The Journal of rheumatology. 26(9)
To examine expression of adhesion molecules within human synovial xenografts in vivo after injection of human cytokines or peripheral blood mononuclear cells (PBMC).Rheumatoid synovium was transplanted into subcutaneous pouches in the ears of severe
Publikováno v:
The Journal of rheumatology. 21(3)
To devise and use a method for assessing the effect of dynamic exercise on synovial blood flow in knees with effusions.The clearance rate of intraarticular 99mTc-DTPA (diethylene triamine pentaacetic acid) was continuously monitored by a gamma camera